2025-05-16 - Analysis Report
Okay, here's a report summarizing the provided data on Teladoc Health Inc. (TDOC).

## Teladoc Health Inc. (TDOC) Stock Analysis

**Company Overview:** Teladoc Health Inc. is a telehealth company that provides virtual healthcare services.

### 1. Performance vs. S&P 500 (VOO)

*   **TDOC Cumulative Return:** -69.19%
*   **VOO Cumulative Return:** 77.92%
*   **Performance Disparity:**
    *   **Current:** -147.1
    *   **Range (Min: -159.2, Max: 454.5)**
    *   **Relative Disparity:** 2.0

**Analysis:** TDOC has significantly underperformed the S&P 500 (VOO). The current disparity is -147.1, placing it near the lower end of its historical range relative to VOO (Relative Disparity of 2.0). This indicates substantial underperformance compared to the market benchmark.

**Alpha, Beta Analysis:**

| Year       | CAGR      | MDD   | Alpha   | Beta   | Cap(B) |
|------------|-----------|-------|---------|--------|--------|
| 2015-2017  | 76.0%     | 60.6% | 52.0%   | -0.0   | 6.1    |
| 2016-2018  | 128.0%    | 59.3% | 112.0%  | -0.0   | 8.7    |
| 2017-2019  | 176.0%    | 59.3% | 149.0%  | 0.3    | 14.7   |
| 2018-2020  | 237.0%    | 64.0% | 212.0%  | 0.1    | 35.1   |
| 2019-2021  | -83.0%    | 64.0% | -136.0% | 0.1    | 16.1   |
| 2020-2022  | -295.0%   | 81.3% | -300.0% | 0.0    | 4.2    |
| 2021-2023  | -488.0%   | 81.3% | -504.0% | -0.6   | 3.8    |
| 2022-2024  | -111.0%   | 81.3% | -127.0% | -0.8   | 1.6    |
| 2023-2025  | -40.0%    | 72.9% | -69.0%  | -0.8   | 1.2    |

**Analysis:**

*   **CAGR:**  CAGR was very high in the 2010s, but has dramatically declined in recent years, indicating severe performance struggles.
*   **MDD:** High MDD values, consistently above 59%, signify significant drawdown risk.
*   **Alpha:** Consistently negative alpha values in recent periods suggest the stock has underperformed relative to its risk (Beta).
*   **Beta:** Beta values are relatively low.
*   **Cap:** The company's Cap decreased dramatically in the latest years, indicating significant capitalization issues.

### 2. Recent Price Action

*   **Current Price:** 7.145
*   **Last-market:** {'price': 7.15, 'previousClose': 7.34, 'change': -2.59}
*   **5-day Moving Average:** 7.109
*   **20-day Moving Average:** 7.0508
*   **60-day Moving Average:** 8.3708

**Analysis:** The stock is trading below its 60-day moving average, but above its 5-day and 20-day moving averages. The `last-market` data indicates a recent price decrease of -2.59%, suggesting bearish short-term momentum.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.3502 (Low Risk)
*   **RSI:** 51.78
*   **PPO:** 1.1708
*   **Recent (20-day) Relative Disparity Change:** -1.1 (Short-term decline)
*   **Expected Return (%):** -4253.7

**Analysis:**

*   The low MRI suggests relatively low market risk.
*   The RSI of 51.78 indicates a neutral momentum.
*   PPO (1.1708) suggests bullish momentum.
*   A negative change in the 20-day relative disparity aligns with a short-term downward trend.
*   The dramatically negative expected return suggests significant long-term underperformance is anticipated.
*   The price drop of -2.59% in the last market should be considered as a short-term bearish signal, potentially influenced by recent news or events.

### 4. Recent News & Significant Events

*   **2025-05-16:** Major business developments, regulatory changes, or market events.
*   **2025-05-14:** Analyst discussions on recent performance and outlook, considering industry trends and global economic factors.
*   **2025-05-12:** Notable stock volatility due to recent news, earnings reports, or executive actions.
*   **2025-05-13:** Market experts highlighting risks and opportunities, advising investors to monitor news and announcements.

**Analysis:** Recent news points to potential volatility and significant events impacting TDOC. Monitoring news and analyst opinions is critical.

### 5. Recent Earnings Analysis

| 날짜         | EPS   | 매출      |
|--------------|-------|-----------|
| 2025-05-01   | -0.53 | 0.63 B$   |
| 2024-10-31   | -0.19 | 0.64 B$   |
| 2024-08-01   | -4.92 | 0.64 B$   |
| 2024-04-26   | -0.49 | 0.65 B$   |
| 2025-05-01   | -0.49 | 0.65 B$   |

**Analysis:** TDOC has been reporting negative EPS. While revenue has been relatively stable around $0.63B - $0.65B, the consistent losses are concerning. The large EPS loss in 2024-08-01 should be further investigated.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-03-31   | $0.63B   | 68.73%        |
| 2024-12-31   | $0.64B   | 70.50%        |
| 2024-09-30   | $0.64B   | 71.94%        |
| 2024-06-30   | $0.64B   | 70.73%        |
| 2024-03-31   | $0.65B   | 69.89%        |

**Capital and Profitability:**

| Quarter      | Equity   | ROE      |
|--------------|----------|----------|
| 2025-03-31   | $1.43B   | -6.52%   |
| 2024-12-31   | $1.49B   | -3.25%   |
| 2024-09-30   | $1.51B   | -2.21%   |
| 2024-06-30   | $1.50B   | -55.77%  |
| 2024-03-31   | $2.29B   | -3.58%   |

**Analysis:**

*   **Revenue:** Revenue has remained relatively consistent.
*   **Profit Margin:** The profit margin is high, which is a positive sign.
*   **Equity:** Equity has been decreasing, especially from Q1 2024 to Q1 2025.
*   **ROE:** Negative ROE values indicate the company is not generating profit from its equity. The large negative ROE in Q2 2024 (-55.77%) requires further investigation.

### 7. Overall Assessment

TDOC is currently exhibiting several concerning trends:

*   **Significant Underperformance:**  The stock has dramatically underperformed the S&P 500, and the expected return is deeply negative.
*   **Negative Earnings:** The company is consistently reporting negative EPS and ROE.
*   **Decreasing Equity:**  Equity is decreasing, raising concerns about the company's financial health.
*   **Volatility:** Recent news suggests potential volatility and significant events impacting the stock.

**Recommendation:** Based on this analysis, caution is advised.  Further research is necessary to understand the reasons behind the negative earnings, decreasing equity, and the specific details of the "major business developments, regulatory changes, or market events" mentioned in the news.  The high profit margin provides *some* reason for optimism, but it is insufficient to outweigh the other negative indicators. Investors should closely monitor the company's upcoming reports and news for any signs of improvement.
